References
- Gillespie SH, Balakrishnan I. Pathogenesis of pneumococcal infection. J Med Microbiol Soci. 2000;49:1057–67.
- Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. [accessed 2020 Apr 8]. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pneumo.pdf
- World Health Organization. Pneumococcal disease [cited 2015 Feb 20]. n.d. [ accessed 2010 February 20]. http://www.who.int/ith/diseases/pneumococcal/en/
- Oligbu G, Hsia Y, Folgori L, Collins S, Ladhani S. Pneumococcal conjugate vaccine failure in children: A systematic review of the literature. Vaccine. 2016;34(50):6126–32. doi:10.1016/j.vaccine.2016.10.050.
- Almeida AF, Sobrinho-Simões J, Ferraz C, Nunes T, Vaz L. Pneumococcal pneumonia vaccine breakthroughs and failures after 13-valent pneumococcal conjugated vaccine. Eur J Public Health. 2016 Oct;26(5):887–89. doi:10.1093/eurpub/ckw089.
- Adebanjo TA, Pondo T, Yankey D, Hill HA, Gierke R, Apostol M, Barnes M, Petit S, Farley M, Harrison LH, et al. Pneumococcal conjugate vaccine breakthrough infections: 2001-2016. Pediatrics. 2020 Feb 13;145(3):pii: e20190836. Forthcoming. doi:10.1542/peds.2019-0836
- Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I. Who is at risk of 13-valent conjugated pneumococcal vaccine failure? Vaccine. 2020;38(7):1671–77. doi:10.1016/j.vaccine.2019.12.060.